David
Santamaría Velilla
Institute Catalá Oncología
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institute Catalá Oncología (2)
2016
-
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
Nature Medicine, Vol. 22, Núm. 3, pp. 270-277
-
KRAS-driven lung adenocarcinoma: Combined DDR1/Notch inhibition as an effective therapy
ESMO Open, Vol. 1, Núm. 5